We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$17.9B
AUM Growth
-$597M
(-3.2%)
Cap. Flow
-$1.32B
Cap. Flow
% of AUM
-7.36%
Top 10 Holdings %
Top 10 Hldgs %
8.81%
Holding
1,709
New
345
Increased
450
Reduced
603
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$146M |
| 2 |
Apple
AAPL
|
+$129M |
| 3 |
Tesla
TSLA
|
+$110M |
| 4 |
Medtronic
MDT
|
+$104M |
| 5 |
Verizon
VZ
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$181M |
| 2 |
Microsoft
MSFT
|
+$177M |
| 3 |
Comcast
CMCSA
|
+$173M |
| 4 |
Adobe
ADBE
|
+$163M |
| 5 |
Broadcom
AVGO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Healthcare | 14.31% |
| 3 | Consumer Discretionary | 12.9% |
| 4 | Industrials | 11.52% |
| 5 | Financials | 10.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Acadia Realty Trust
AKR
$2.84B
| $1.17M | 0.01% |
81,302
-51,474
| -39% | -$727K |
|
1102
Kodiak Sciences
KOD
$2.72B
| $1.16M | 0.01% |
162,662
-137,015
| -46% | -$983K |
|
1103
Relmada Therapeutics
RLMD
$503M
| $1.16M | 0.01% |
333,097
+228,826
| +219% | +$2.01M |
|
1104
Brookfield Infrastructure
BIPC
$4.93B
| $1.16M | 0.01% |
29,855
-54,676
| -65% | -$2.32M |
|
1105
Ionis Pharmaceuticals
IONS
$9.39B
| $1.16M | 0.01% |
+30,709
| New | +$1.29M |
|
1106
Quest Diagnostics
DGX
$26.2B
| $1.16M | 0.01% |
+7,391
| New | +$1.06M |
|
1107
Flowserve
FLS
$10.3B
| $1.14M | 0.01% |
+37,187
| New | +$1.08M |
|
1108
Sempra
SRE
$56.2B
| $1.14M | 0.01% |
14,690
-185,802
| -93% | -$14.4M |
|
1109
SPX Corp
SPXC
$10.9B
| $1.13M | 0.01% |
+17,239
| New | +$1.13M |
|
|
CSW
1110
CSW Industrials
CSW
$5.65B
| $1.13M | 0.01% |
+9,708
| New | +$1.16M |
|
1111
Repligen
RGEN
$9.35B
| $1.12M | 0.01% |
6,611
-470
| -7% | -$85.3K |
|
1112
Asbury Automotive
ABG
$3.76B
| $1.1M | 0.01% |
+6,161
| New | +$1.03M |
|
1113
Snowflake
SNOW
$115B
| $1.1M | 0.01% |
7,629
-148,034
| -95% | -$22.6M |
|
1114
Ingles Markets
IMKTA
$1.66B
| $1.09M | 0.01% |
11,347
+6,574
| +138% | +$617K |
|
|
AVID
1115
DELISTED
Avid Technology Inc
AVID
| $1.09M | 0.01% |
41,133
-62,896
| -60% | -$1.66M |
|
1116
Amplitude
AMPL
$1.55B
| $1.09M | 0.01% |
90,391
-193,541
| -68% | -$2.74M |
|
|
ITOS
1117
DELISTED
iTeos Therapeutics
ITOS
| $1.09M | 0.01% |
55,691
-46,260
| -45% | -$904K |
|
1118
Repay Holdings
RPAY
$311M
| $1.07M | 0.01% |
133,491
+71,530
| +115% | +$515K |
|
1119
Portillo's
PTLO
$345M
| $1.07M | 0.01% |
65,748
-99,487
| -60% | -$1.99M |
|
|
CAJ
1120
DELISTED
Canon, Inc.
CAJ
| $1.07M | 0.01% |
+49,140
| New | +$1.1M |
|
|
AL
1121
DELISTED
Air Lease Corp
AL
| $1.06M | 0.01% |
+27,686
| New | +$996K |
|
1122
Timken Company
TKR
$9.03B
| $1.06M | 0.01% |
14,986
-842
| -5% | -$58.8K |
|
|
TUP
1123
DELISTED
Tupperware Brands Corporation
TUP
| $1.06M | 0.01% |
255,330
-232,870
| -48% | -$1.25M |
|
1124
Check Point Software Technologies
CHKP
$13.2B
| $1.06M | 0.01% |
8,372
+2,144
| +34% | +$268K |
|
1125
Vontier
VNT
$4.52B
| $1.06M | 0.01% |
+54,594
| New | +$1.02M |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, Voloridge Investment Management held 1,709 positions worth $17.9B, down 3.2% from $18.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management withdrew a net $1.32B in Q4 2022, closing 311 positions and reducing 603 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $181M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in Edwards Lifesciences worth $142M.
- Voloridge Investment Management's largest Q4 2022 buy was Edwards Lifesciences: 1,898,822 shares worth $142M.
- Voloridge Investment Management added most to Tesla in Q4 2022, an estimated $110M increase.
- Voloridge Investment Management's biggest Q4 2022 reduction was Microsoft, cutting an estimated $177M.
- Voloridge Investment Management fully exited Berkshire Hathaway Class B in Q4 2022, selling an estimated $181M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $17.9B portfolio in Q4 2022.
- Voloridge Investment Management opened 345 new positions and closed 311 in Q4 2022.
- Voloridge Investment Management's portfolio value fell 3.2% quarter-over-quarter to $17.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.